KELER TIBOR
Transactions
26
Companies
1
Filings
18
CIK
0001429931
Recent Transactions
- Award
Incentive Stock Option (right to buy)
2026-06-25+115,000→ 115,000 total - Award
- Award
- Award
- Sale
Common Stock, par value $0.001 per share
2022-12-07$36.93/sh−16,860→ 7,357 total - Exercise/Conversion
Common Stock, par value $0.001 per share
2022-12-07$2.78/sh+16,860→ 24,217 total - Exercise/Conversion
- Award
- Award
- Award
Incentive Stock Option (right to buy)
2020-06-18+108,000→ 108,000 total - Purchase
Common Stock, par value $0.001 per share
2020-06-09$2.99/sh+5,000→ 7,357 total - Award
- Purchase
Common Stock, par value $0.001 per share
2018-06-15$0.59/sh+16,500→ 35,368 total - Award
Incentive Stock Option (right to buy)
2018-06-13+390,000→ 390,000 total - Award
Incentive Stock Option (right to buy)
2017-06-15+162,000→ 162,000 total - Purchase
Common Stock, par value $0.001 per share
2016-09-02$3.32/sh+3,000→ 18,868 total - Award
- Award
- Award
- Award
- Purchase
- Award
- Purchase
- Award
- Award
- Award
Companies
1Recent Filings
18- 4
KELER TIBOR
Jun 29, 2026
- 4
KELER TIBOR
Jun 9, 2025
- 4
KELER TIBOR
Jun 17, 2024
- 4
KELER TIBOR
Jun 20, 2023
- 4
KELER TIBOR
Dec 9, 2022
- 4
KELER TIBOR
Jun 17, 2022
- 4
KELER TIBOR
Jun 21, 2021
- 4
KELER TIBOR
Jun 19, 2020
- 4
KELER TIBOR
Jun 10, 2020
- 4
KELER TIBOR
Jun 20, 2019
- 4
KELER TIBOR
Jun 18, 2018
- 4
KELER TIBOR
Jun 15, 2018
- 4
Celldex Therapeutics, Inc.
Jun 16, 2017
- 4
Celldex Therapeutics, Inc.
Sep 6, 2016
- 4
Celldex Therapeutics, Inc.
Jun 9, 2016
- 4
Celldex Therapeutics, Inc.
Jun 11, 2015
- 4
Celldex Therapeutics, Inc.
Jul 3, 2013
- 4
KELER TIBOR
Sep 13, 2012
Address
C/O CELLDEX THERAPEUTICS, INC. 53 FRONTAGE ROAD, SUITE 220
HAMPTON, NJ, 08827